WallStreetZenWallStreetZen

NYSE: UHS
Universal Health Services Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for UHS

Based on 9 analysts offering 12 month price targets for Universal Health Services Inc

Min Forecast
$203.00-1.68%
Avg Forecast
$246.78+19.53%
Max Forecast
$302.00+46.28%

Should I buy or sell UHS stock?

Based on 9 analysts offering ratings for Universal Health Services Inc.

Buy
Strong Buy
4 analysts 44.44%
Buy
0 analysts 0%
Hold
5 analysts 55.56%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their UHS stock forecasts and price targets.

UHS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-01-22
lockedlocked$00.00+00.00%2026-01-07
lockedlocked$00.00+00.00%2026-01-07
lockedlocked$00.00+00.00%2025-12-02
lockedlocked$00.00+00.00%2025-10-30
UBS
Top 12%
89
Strong BuyMaintains$302.00+46.28%2025-10-29
Cantor Fitzgerald
Bottom 1%
1
HoldMaintains$250.00+21.09%2025-10-29
Goldman Sachs
Top 15%
86
HoldAssumes$219.00+6.07%2025-10-14
Baird
Bottom 6%
6
HoldMaintains$203.00-1.68%2025-08-14

1 of 1

Forecast return on equity

Is UHS forecast to generate an efficient return?

Company
27.35%
Industry
-118.02%
Market
216.29%
UHS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is UHS forecast to generate an efficient return on assets?

Company
12.78%
Industry
12.8%
UHS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

UHS earnings per share forecast

What is UHS's earnings per share in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$23.75+11.36%
Avg 2 year Forecast
$26.52+24.33%
Avg 3 year Forecast
$28.74+34.76%
UHS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

UHS revenue forecast

What is UHS's revenue in the next 3 years based on estimates from 20 analysts?

Avg 1 year Forecast
$18.4B+8.45%
Avg 2 year Forecast
$19.4B+14.1%
Avg 3 year Forecast
$19.5B+14.56%
UHS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

UHS earnings growth forecast

How is UHS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
10.89%
Industry
17.41%
Market
39.92%
UHS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
UHS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
UHS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

UHS revenue growth forecast

How is UHS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
5.61%
Industry
5.27%
Market
22.81%
UHS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
UHS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

UHS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
UHS$206.46$246.78+19.53%Buy
FMS$23.81N/AN/A
ENSG$173.18$206.50+19.24%Strong Buy
DVA$142.06$154.33+8.64%Hold
EHC$95.66$148.00+54.71%Strong Buy
View Top Medical Care Facility Stocks

Universal Health Services Stock Forecast FAQ

Is Universal Health Services Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 9 Wall Street analysts covering (NYSE: UHS) stock is to Buy UHS stock.

Out of 9 analysts, 4 (44.44%) are recommending UHS as a Strong Buy, 0 (0%) are recommending UHS as a Buy, 5 (55.56%) are recommending UHS as a Hold, 0 (0%) are recommending UHS as a Sell, and 0 (0%) are recommending UHS as a Strong Sell.

If you're new to stock investing, here's how to buy Universal Health Services stock.

What is UHS's earnings growth forecast for 2026-2028?

(NYSE: UHS) Universal Health Services's forecast annual earnings growth rate of 10.89% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 17.41%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 39.92%.

Universal Health Services's earnings in 2026 is $1,375,252,000.On average, 20 Wall Street analysts forecast UHS's earnings for 2026 to be $1,484,202,724, with the lowest UHS earnings forecast at $1,363,042,936, and the highest UHS earnings forecast at $1,620,483,274. On average, 16 Wall Street analysts forecast UHS's earnings for 2027 to be $1,657,004,287, with the lowest UHS earnings forecast at $1,528,983,922, and the highest UHS earnings forecast at $1,806,806,048.

In 2028, UHS is forecast to generate $1,796,034,067 in earnings, with the lowest earnings forecast at $1,742,686,521 and the highest earnings forecast at $1,867,164,129.

What is UHS's revenue growth forecast for 2026-2028?

(NYSE: UHS) Universal Health Services's forecast annual revenue growth rate of 5.61% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.27%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 22.81%.

Universal Health Services's revenue in 2026 is $16,992,503,000.On average, 20 Wall Street analysts forecast UHS's revenue for 2026 to be $1,151,427,252,008, with the lowest UHS revenue forecast at $1,094,943,084,664, and the highest UHS revenue forecast at $1,225,281,550,460. On average, 16 Wall Street analysts forecast UHS's revenue for 2027 to be $1,211,472,921,054, with the lowest UHS revenue forecast at $1,138,118,482,490, and the highest UHS revenue forecast at $1,294,449,662,462.

In 2028, UHS is forecast to generate $1,216,284,072,476 in revenue, with the lowest revenue forecast at $1,180,106,713,082 and the highest revenue forecast at $1,264,458,069,182.

What is UHS's forecast return on assets (ROA) for 2026-2029?

(NYSE: UHS) forecast ROA is 12.78%, which is lower than the forecast US Medical Care Facilities industry average of 12.8%.

What is UHS's Price Target?

According to 9 Wall Street analysts that have issued a 1 year UHS price target, the average UHS price target is $246.78, with the highest UHS stock price forecast at $302.00 and the lowest UHS stock price forecast at $203.00.

On average, Wall Street analysts predict that Universal Health Services's share price could reach $246.78 by Jan 22, 2027. The average Universal Health Services stock price prediction forecasts a potential upside of 19.53% from the current UHS share price of $206.46.

What is UHS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: UHS) Universal Health Services's current Earnings Per Share (EPS) is $21.33. On average, analysts forecast that UHS's EPS will be $23.75 for 2026, with the lowest EPS forecast at $21.81, and the highest EPS forecast at $25.94. On average, analysts forecast that UHS's EPS will be $26.52 for 2027, with the lowest EPS forecast at $24.47, and the highest EPS forecast at $28.92. In 2028, UHS's EPS is forecast to hit $28.74 (min: $27.89, max: $29.88).

What is UHS's forecast return on equity (ROE) for 2026-2029?

(NYSE: UHS) forecast ROE is 27.35%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.